CFO4Life Group, LLC

Position in MRK — Merck & Co., Inc.

CIK 1706351 COPPELL, TX

Position in MRK

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$327,546

+$37,527 QoQ

Shares Held

2,549

+5.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#3,084

of 3,769 holders

Holding Since

Mar 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CFO4Life Group, LLC holds $7,374,448 across 8 Drug Manufacturers - General names. MRK ranks #8 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	10,539	$2,676,589
2	LLY	ELI LILLY & Co	1,589	$1,905,894
3	NVS	Novartis AG	4,916	$770,435
4	AMGN	Amgen Inc	1,340	$485,240
5	ABBV	AbbVie Inc.	1,745	$439,111
6	GILD	Gilead Sciences, Inc.	3,156	$398,729
7	PFE	Pfizer Inc	15,403	$370,904
8	MRK	Merck & Co., Inc. This page	2,549	$327,546

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$327,546	2,549	+5.7%	Shares	Sole	2026-08-12
2026-03-31	$290,019	2,411	-5.4%	Shares	Sole	2026-05-11
2025-12-31	$268,202	2,548	-6.4%	Shares	Sole	2026-02-06
2025-09-30	$228,373	2,721	-2.7%	Shares	Sole	2025-11-07
2025-03-31	$251,058	2,797	+6.3%	Shares	Sole	2025-04-30
2024-12-31	$261,632	2,630	-6.4%	Shares	Sole	2025-02-10
2024-09-30	$318,990	2,809	-2.6%	Shares	Sole	2024-11-12
2024-06-30	$357,039	2,884	+9.5%	Shares	Sole	2024-07-31
2024-03-31	$347,424	2,633	-5.6%	Shares	Sole	2024-05-06
2023-12-31	$304,165	2,790	+0.2%	Shares	Sole	2024-02-12
2023-09-30	$286,612	2,784	-67.1%	Shares	Sole	2023-10-30
2023-06-30	$975,853	8,457	+8.0%	Shares	Sole	2023-08-07
2023-03-31	$832,820	7,828	+9.7%	Shares	Sole	2023-05-03
2022-12-31	$791,739	7,136	+210.7%	Shares	Sole	2023-02-03
2022-06-30	$209,417	2,297	-7.4%	Shares	Sole	2022-07-20
2022-03-31	$203,484	2,480	—	Shares	Sole	2022-05-02
No filing history on record for this holder in this stock.